Alogliptin plus metformin combination therapy vs alogliptin or metformin monotherapy for type 2 diabetes mellitus

被引：0
|
作者：
Pratley, R. [1 ,2 ]
Wilson, C. [3 ]
Fleck, P. [3 ]
机构：
[1] Florida Hosp, Diabet & Translat Res Inst, Orlando, FL USA
[2] Sanford Burnham Inst, Orlando, FL USA
[3] Takeda Global Res & Dev Ctr Inc, Deerfield, IL USA
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
841
引用
收藏
页码：S347 / S348
页数：2
相关论文
共 50 条
  • [21] Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
    Caturano, Alfredo
    Galiero, Raffaele
    Loffredo, Giuseppe
    Vetrano, Erica
    Medicamento, Giulia
    Acierno, Carlo
    Rinaldi, Luca
    Marrone, Aldo
    Salvatore, Teresa
    Monda, Marcellino
    Sardu, Celestino
    Marfella, Raffaele
    Sasso, Ferdinando Carlo
    BIOMEDICINES, 2023, 11 (02)
  • [22] Metformin monotherapy for adults with type 2 diabetes mellitus
    Gnesin, Filip
    Thuesen, Anne Cathrine Baun
    Kahler, Lise Katrine Aronsen
    Madsbad, Sten
    Hemmingsen, Bianca
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06):
  • [23] The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
    Reasner, C.
    Olansky, L.
    Seck, T. L.
    Williams-Herman, D. E.
    Chen, M.
    Terranella, L.
    Johnson-Levonas, A. O.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 644 - 652
  • [24] Pharmacokinetics and clinical evaluation of the alogliptin plus pioglitazone combination for type 2 diabetes
    Scheen, Andre J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (06) : 1005 - 1020
  • [25] Efficacy and Safety of Gosogliptin as Monotherapy and in Combination with Metformin in Patients with Type 2 Diabetes Mellitus
    Trakhtenberg, Julia
    Vostokova, Natalia
    Karavaeva, Oksana
    Kreminskaya, Vera
    Ametov, Alexander
    DIABETES, 2015, 64 : A329 - A330
  • [26] Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial
    Park, Ji-Yeon
    Lee, Joonyub
    Choi, Yoon-Hee
    Min, Wan
    Han, Kyung Ah
    Ahn, Kyu Jeung
    Lim, Soo
    Kim, Young-Hyun
    Ahn, Chul Woo
    Choi, Kyung Mook
    Yoon, Kun-Ho
    DIABETES & METABOLISM JOURNAL, 2024, 48 (05)
  • [27] Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naive patients with type 2 diabetes: a randomized, double-blind, 6-month study
    Pratley, R. E.
    Fleck, P.
    Wilson, C.
    DIABETES OBESITY & METABOLISM, 2014, 16 (07): : 613 - 621
  • [28] Effects of Pioglitazone and Metformin Combination Therapy on High-Molecular-Weight Adiponectin Compared With Metformin Monotherapy in Type 2 Diabetes Mellitus Patients
    Matsushita, Takaya
    Kaji, Akino
    Kaji, Kuniaki
    Takahashi, Eri
    Usui, Takahiro
    Asahi, Nobuteru
    Sato, Tomoya
    Ohono, Atushi
    Ueki, Akio
    DIABETES, 2012, 61 : A626 - A626
  • [29] POSSIBILITIES OF APPLICATION A FIXED COMBINATION OF ALOGLIPTIN AND PIOGLITAZONE FOR TYPE 2 DIABETES MELLITUS TREATMENT
    Shestakova, Marina, V
    Antsiferov, Mikhail B.
    Ametov, Alexander S.
    Galstyan, Gagik R.
    Demidova, Tatiana Yu
    Mkrtumyan, Ashot M.
    Petunina, Nina A.
    DIABETES MELLITUS, 2021, 24 (02): : 193 - 197
  • [30] Effect of alogliptin combined with pioglitazone on glycaemic control in metformin-treated patients with type 2 diabetes
    DeFronzo, R.
    Burant, C.
    Fleck, P.
    Wilson, C.
    Mekki, Q.
    Pratley, R.
    DIABETOLOGIA, 2009, 52 : S295 - S295
12345